Cargando…

Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study

Background: Donor-derived cell-free DNA (ddcfDNA) has been suggested as an indicator of allograft injury in adult and pediatric kidney transplantation (KTx). However, the dynamics of ddcfDNA in pediatric KTx have not been investigated. In addition, it has not been demonstrated whether donor-recipien...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Weijian, Su, Xiaojun, Liu, Longshan, Li, Jun, Fu, Qian, Li, Xirui, Wu, Chenglin, Wang, Jiali, Deng, Ronghai, Chen, E., Yang, Shicong, Li, Shujuan, Zhang, Huanxi, Wang, Changxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777035/
https://www.ncbi.nlm.nih.gov/pubmed/35071284
http://dx.doi.org/10.3389/fmed.2021.814517
_version_ 1784636972882460672
author Nie, Weijian
Su, Xiaojun
Liu, Longshan
Li, Jun
Fu, Qian
Li, Xirui
Wu, Chenglin
Wang, Jiali
Deng, Ronghai
Chen, E.
Yang, Shicong
Li, Shujuan
Zhang, Huanxi
Wang, Changxi
author_facet Nie, Weijian
Su, Xiaojun
Liu, Longshan
Li, Jun
Fu, Qian
Li, Xirui
Wu, Chenglin
Wang, Jiali
Deng, Ronghai
Chen, E.
Yang, Shicong
Li, Shujuan
Zhang, Huanxi
Wang, Changxi
author_sort Nie, Weijian
collection PubMed
description Background: Donor-derived cell-free DNA (ddcfDNA) has been suggested as an indicator of allograft injury in adult and pediatric kidney transplantation (KTx). However, the dynamics of ddcfDNA in pediatric KTx have not been investigated. In addition, it has not been demonstrated whether donor-recipient (D/R) size mismatch affect ddcfDNA level. Methods: Pediatric KTx recipients with a single donor kidney were enrolled and followed up for 1 year. ddcfDNA, calculated as a fraction (%) in the recipient plasma, was examined longitudinally within 3 months post-transplant. D/R size mismatch degree was described as D/R height ratio. The 33rd percentile of D/R height ratio (0.70) was used as the cut-off to divide the patients into low donor-recipient height ratio group (<0.70) and high donor-recipient height ratio group (≥0.70). The dynamics of ddcfDNA were analyzed and the impact factors were explored. Stable ddcfDNA was defined as the first lowest ddcfDNA. ddcfDNA flare-up was defined as a remarkable elevation by a proportion of >30% from stable value with a peak value >1% during elevation. Results: Twenty-one clinically stable recipients were enrolled. The median D/R height ratio was 0.83 (0.62–0.88). It took a median of 8 days for ddcfDNA to drop from day 1 and reach a stable value of 0.67% (0.46–0.73%). Nevertheless, 61.5% patients presented ddcfDNA>1% at day 30. Besides, 81.0% (17/21) of patients experienced elevated ddcfDNA and 47.6% (10/21) met the standard of ddcfDNA flare-up. Donor-recipient height ratio was an independent risk factor for ddcfDNA flare-up (odds ratio = 0.469 per 0.1, 95% CI 0.237–0.925, p = 0.029) and low donor-recipient height ratio (<0.70) was found to increase the risk of flare-up occurrence (odds ratio = 15.00, 95% CI 1.342–167.638, p = 0.028). Conclusions: ddcfDNA rebounds in many stable pediatric KTx recipients without rejection. This may be induced by significant D/R size mismatch and may affect its diagnostic performance at the early phase after pediatric KTx in children.
format Online
Article
Text
id pubmed-8777035
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87770352022-01-22 Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study Nie, Weijian Su, Xiaojun Liu, Longshan Li, Jun Fu, Qian Li, Xirui Wu, Chenglin Wang, Jiali Deng, Ronghai Chen, E. Yang, Shicong Li, Shujuan Zhang, Huanxi Wang, Changxi Front Med (Lausanne) Medicine Background: Donor-derived cell-free DNA (ddcfDNA) has been suggested as an indicator of allograft injury in adult and pediatric kidney transplantation (KTx). However, the dynamics of ddcfDNA in pediatric KTx have not been investigated. In addition, it has not been demonstrated whether donor-recipient (D/R) size mismatch affect ddcfDNA level. Methods: Pediatric KTx recipients with a single donor kidney were enrolled and followed up for 1 year. ddcfDNA, calculated as a fraction (%) in the recipient plasma, was examined longitudinally within 3 months post-transplant. D/R size mismatch degree was described as D/R height ratio. The 33rd percentile of D/R height ratio (0.70) was used as the cut-off to divide the patients into low donor-recipient height ratio group (<0.70) and high donor-recipient height ratio group (≥0.70). The dynamics of ddcfDNA were analyzed and the impact factors were explored. Stable ddcfDNA was defined as the first lowest ddcfDNA. ddcfDNA flare-up was defined as a remarkable elevation by a proportion of >30% from stable value with a peak value >1% during elevation. Results: Twenty-one clinically stable recipients were enrolled. The median D/R height ratio was 0.83 (0.62–0.88). It took a median of 8 days for ddcfDNA to drop from day 1 and reach a stable value of 0.67% (0.46–0.73%). Nevertheless, 61.5% patients presented ddcfDNA>1% at day 30. Besides, 81.0% (17/21) of patients experienced elevated ddcfDNA and 47.6% (10/21) met the standard of ddcfDNA flare-up. Donor-recipient height ratio was an independent risk factor for ddcfDNA flare-up (odds ratio = 0.469 per 0.1, 95% CI 0.237–0.925, p = 0.029) and low donor-recipient height ratio (<0.70) was found to increase the risk of flare-up occurrence (odds ratio = 15.00, 95% CI 1.342–167.638, p = 0.028). Conclusions: ddcfDNA rebounds in many stable pediatric KTx recipients without rejection. This may be induced by significant D/R size mismatch and may affect its diagnostic performance at the early phase after pediatric KTx in children. Frontiers Media S.A. 2022-01-07 /pmc/articles/PMC8777035/ /pubmed/35071284 http://dx.doi.org/10.3389/fmed.2021.814517 Text en Copyright © 2022 Nie, Su, Liu, Li, Fu, Li, Wu, Wang, Deng, Chen, Yang, Li, Zhang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Nie, Weijian
Su, Xiaojun
Liu, Longshan
Li, Jun
Fu, Qian
Li, Xirui
Wu, Chenglin
Wang, Jiali
Deng, Ronghai
Chen, E.
Yang, Shicong
Li, Shujuan
Zhang, Huanxi
Wang, Changxi
Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
title Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
title_full Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
title_fullStr Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
title_full_unstemmed Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
title_short Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
title_sort dynamics of donor-derived cell-free dna at the early phase after pediatric kidney transplantation: a prospective cohort study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777035/
https://www.ncbi.nlm.nih.gov/pubmed/35071284
http://dx.doi.org/10.3389/fmed.2021.814517
work_keys_str_mv AT nieweijian dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT suxiaojun dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT liulongshan dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT lijun dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT fuqian dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT lixirui dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT wuchenglin dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT wangjiali dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT dengronghai dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT chene dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT yangshicong dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT lishujuan dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT zhanghuanxi dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy
AT wangchangxi dynamicsofdonorderivedcellfreednaattheearlyphaseafterpediatrickidneytransplantationaprospectivecohortstudy